CClinicalTrials.gg
WithdrawnNCT02561715Updated Mar 25, 2020

Lack of Awareness of Symptoms (Anosognosia) in PD: An Observational Study for People With Parkinson's

An observational study in Parkinson's and Anosognosia, sponsored by University of Birmingham. Withdrawn at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-03-25.

Sponsored by University of Birmingham · Observational

Why this study was withdrawn
Lack of funding
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
0
Ages
18 Years and older
Sex
All
01

Study summary

Anosognosia is a recognised condition for people with Parkinson's, and is the result of physiological damage on brain structure.

Surgical Parkinson Disease Nurse Specialists have noticed that when reviewing the pre-surgery videos 12 months post-DBS, patients have forgotten and are shocked at how bad their symptoms were prior to surgery (personal communication), which may not be reflected in the change in QoL reported.

This lack of awareness, while possibly helpful in everyday life, may lead to effective treatments looking ineffective, or the benefits in QoL of effective treatment appearing reduced. This confound may not only reduce the apparent effectiveness but also the related cost-effectiveness of treatment. As cost-effectiveness is determined by both size and longevity of an effect, current methods of capturing these data may be suboptimal.

Read the detailed description

The overarching aim of this project is to identify coping mechanisms and pathological lack of self-awareness and the impact they are likely to have on patient reported quality of life (QoL) outcome measures for a chronic condition.

This will be an observational study, a case series of approx. 10 to 20 patients. These patients will be recruited over a 6 month period from the Queen Elizabeth Hospital, Birmingham and will be informed of the study during their routine pre-surgical visit.

Patients will be eligible if they are about to undergo DBS at Queen Elizabeth Hospital. If the participant has a carer, who is also willing to participate, they may also join the study. Patients will be excluded if they are unable to complete questionnaires in English.

Once recruited and following consent, a patient will complete a brief battery of questionnaires both self-reported and clinician rated prior to surgery and at their 6 month post op visit.

02

Conditions studied

  • Parkinson's
  • Anosognosia

Keywords

  • Parkinson's
  • Anosognosia
  • DBS
  • Deep Brain Surgery
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

Browse Parkinson Disease studies →

Lead sponsor

University of Birmingham is the lead sponsor of 179 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with Parkinson's due for deep brain surgery

Inclusion criteria

  • Clinical diagnosis of Parkinson's as defined by the UK PDS Brain Bank Criteria

Exclusion criteria

Exclusion Criteria:

  • Unable to complete questionnaires in English.
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
0 participants (actual)
Patient registry
No

Interventions

  • BehavioralQuestionnaires

    Pre and post deep brain surgery questionnaires

06

What researchers measure

Primary outcomes

  1. Improvement of ability to recall extent of condition

    Person with Parkinson's specific quality of life using the Parkinson's Disease Questionnaire for both participant and carer.

    Time frame: 9 months

Secondary outcomes

  1. Clinician's Rating Scale for Evaluating Impaired Self Awareness and Denial of Disability after Brain Injury adapted for use with PD patients.after Brain Injury, adapted for use with Parkinson's Disease patients

    Participants self-awareness of their Parkinson's

    Time frame: 9 months

  2. Patient Generated Index

    Quality of life measure

    Time frame: 9 months

  3. Abnormal Involuntary Movement Scale

    Occurrence of tardive dyskinesia

    Time frame: 9 months

  4. Patient Competency Rating Scale

    Evaluation of self-awareness following traumatic brain injury

    Time frame: 9 months

  5. Grooved peg board test

    Measuring motor performance

    Time frame: 9 months

  6. The tapping test

    Measuring motor control

    Time frame: 9 months

  7. Unified Parkinson's Disease Rating Scale

    Rating the extent of the participant's Parkinson's

    Time frame: 9 months

  8. Mini Mental State Exam

    Measure of cognitive impairment

    Time frame: 9 months

  9. Parkinson's' Disease Questionnaire

    PDQ-39 (Carer)

    Time frame: 9 months

07

Study locations

1 site
  • Queen Elizabeth Hospital
    Birmingham, B15 2TT, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 25, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02561715
Lead sponsor
University of Birmingham
Responsible party
Sponsor
First posted
Sep 28, 2015
Start date
Aug 1, 2015
Primary completion
Jul 18, 2019
Completion
Jul 18, 2019
Last update
Mar 25, 2020

Study contacts

Hardev Pall, MD
principal investigator · Queen Elizabeth Medical Centre, Birmingham, UK

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion